Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cresco Labs to Report Third Quarter 2023 Financial Results on November 15, 2023 By: Cresco Labs via Business Wire November 01, 2023 at 07:30 AM EDT Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the third quarter 2023 on Wednesday, November 15th, 2023 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. Event: Cresco Labs Third Quarter 2023 Earnings Conference Call Date: Wednesday, November 15th, 2023 Time: 8:30 am EST Webcast: LINK Dial-in: 1-833-470-1428 (US Toll Free), 1-646-904-5544 (US Local) Access Code: 259018 Archived access to the webcast will be available for one year on the Cresco Labs investor relations website. About Cresco Labs Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn. View source version on businesswire.com: https://www.businesswire.com/news/home/20231101545114/en/Contacts Media: Jason Erkes, Cresco Labs Chief Communications Officer press@crescolabs.com Investors: Megan Kulick, Cresco Labs Senior Vice President, Investor Relations investors@crescolabs.com For general Cresco Labs inquiries: 312-929-0993 info@crescolabs.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Cresco Labs to Report Third Quarter 2023 Financial Results on November 15, 2023 By: Cresco Labs via Business Wire November 01, 2023 at 07:30 AM EDT Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the third quarter 2023 on Wednesday, November 15th, 2023 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. Event: Cresco Labs Third Quarter 2023 Earnings Conference Call Date: Wednesday, November 15th, 2023 Time: 8:30 am EST Webcast: LINK Dial-in: 1-833-470-1428 (US Toll Free), 1-646-904-5544 (US Local) Access Code: 259018 Archived access to the webcast will be available for one year on the Cresco Labs investor relations website. About Cresco Labs Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn. View source version on businesswire.com: https://www.businesswire.com/news/home/20231101545114/en/Contacts Media: Jason Erkes, Cresco Labs Chief Communications Officer press@crescolabs.com Investors: Megan Kulick, Cresco Labs Senior Vice President, Investor Relations investors@crescolabs.com For general Cresco Labs inquiries: 312-929-0993 info@crescolabs.com
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the third quarter 2023 on Wednesday, November 15th, 2023 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. Event: Cresco Labs Third Quarter 2023 Earnings Conference Call Date: Wednesday, November 15th, 2023 Time: 8:30 am EST Webcast: LINK Dial-in: 1-833-470-1428 (US Toll Free), 1-646-904-5544 (US Local) Access Code: 259018 Archived access to the webcast will be available for one year on the Cresco Labs investor relations website. About Cresco Labs Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn. View source version on businesswire.com: https://www.businesswire.com/news/home/20231101545114/en/
Media: Jason Erkes, Cresco Labs Chief Communications Officer press@crescolabs.com Investors: Megan Kulick, Cresco Labs Senior Vice President, Investor Relations investors@crescolabs.com For general Cresco Labs inquiries: 312-929-0993 info@crescolabs.com